Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult Ambulatory Care Visits

Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult Ambulatory Care Visits

Abstract The Food and Drug Administration warned against fluoroquinolone use for conditions with effective alternative agents. An estimated 5.1% of adult ambulatory fluoroquinolone prescriptions were for conditions that did not require antibiotics, and 19.9% were for conditions where fluoroquinolone...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical infectious diseases 2018-06, Vol.67 (1), p.134-136
Hauptverfasser: Kabbani, Sarah, Hersh, Adam L, Shapiro, Daniel J, Fleming-Dutra, Katherine E, Pavia, Andrew T, Hicks, Lauri A
Format: Artikel
Sprache:eng
Schlagworte:
Ambulatory care
Antibiotics
Brief Reports
Emergency medical services
Fluoroquinolones
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract The Food and Drug Administration warned against fluoroquinolone use for conditions with effective alternative agents. An estimated 5.1% of adult ambulatory fluoroquinolone prescriptions were for conditions that did not require antibiotics, and 19.9% were for conditions where fluoroquinolones are not recommended first-line therapy. Unnecessary fluoroquinolone use should be reduced.
ISSN:1058-4838
1537-6591
DOI:10.1093/cid/ciy035